Back to search

Article

Identification of a novel HASPIN inhibitor and its synergism with the PLK1 inhibitor

2022-09-07

Abstract excerpt

<h4>Background: </h4> HASPIN, a mitotic kinase for Histone H3, is a promising target for anti-cancer therapy. However, as HASPIN is an atypical kinase with low similarity to eukaryotic protein kinases, development of a HASPIN inhibitor from the conventional pharmacophore of kinase inhibitors would be technically challenging. <h4>Methods: </h4>: Chemical modifications of a cytotoxic 4’-thioadenosine analogue with h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b0bc62a-f11c-59ee-af34-558c5e51d1a6
DOI
10.21203/rs.3.rs-2027316/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identification of a novel HASPIN inhibitor and its synergism with the PLK1 inhibitorDOI 10.21203/rs.3.rs-2027316/v1
Select a neighboring publication to make it the new centre.